(Q42994283)

English

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

scientific article published in July 2010

Statements

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial (English)
Peter Dreger
Matthias Ritgen
Sebastian Böttcher
Raymonde Busch
Sascha Dietrich
Donald Bunjes
Sandra Cohen
Jörg Schubert
Ute Hegenbart
Dietrich Beelen
Matthias Zeis
Michael Stadler
Justin Hasenkamp
Lutz Uharek
Christof Scheid
Andreas Humpe
Dirk Winkler
Michael Kneba
Norbert Schmitz
German CLL Study Group
1 July 2010
2438-2447

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit